Related Experiment Video
Updated: Jul 26, 2025

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
Miniature Palpebral Plexiform Neurofibroma in Neurofibromatosis Type 2
Norman C Charles1,2, Eleanore T Kim1
1Department of Ophthalmology, New York University Langone Medical Center, New York, U.S.A.
A rare eyelid plexiform neurofibroma was identified in a neurofibromatosis 2 patient. This case highlights unusual cutaneous manifestations in neurofibromatosis 2, expanding understanding of these complex genetic disorders.
Area of Science:
- Dermatology
- Oncology
- Genetics
Background:
- Neurofibromatosis 2 (NF2) is a genetic disorder primarily associated with tumors of the nervous system.
- Cutaneous manifestations in NF2 are less common and not extensively studied compared to NF1.
- Plexiform neurofibromas are rare tumors, typically associated with NF1.
Observation:
- A 27-year-old woman with NF2 presented with a slow-growing, painless nodular lesion on her left upper eyelid.
- The lesion was surgically excised for diagnosis and further examination.
Findings:
- Histopathology confirmed a plexiform neurofibroma with intradermal nodules.
- Immunohistochemistry revealed diffuse SOX-10 and S100 reactivity, with focal neurofilament and CD34 expression.
- Nodules were surrounded by perineurium positive for epithelial membrane antigen (EMA) and glucose transporter 1 (GLUT1).
Implications:
- This case represents a rare instance of a plexiform neurofibroma occurring in an eyelid of an NF2 patient.
- It contributes to the limited literature on cutaneous abnormalities in NF2.
- The findings underscore the importance of comprehensive evaluation for diverse tumor types in NF2 patients.
More Related Videos
05:44Author Spotlight: Collecting the Brain and Serum from the Same Mice Fetus to Study Brain Tumor Development
Published on: May 17, 2024
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021